Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of OROS-Methylphenidate on Attention and Working Memory in Children With ADHD
NCT00530257Phase 4Completed
- Sponsor
- Children's Hospital of Philadelphia
- Start
- Jun 2004
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Children's Hospital of Philadelphia. Started Jun 2004; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00530257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00530257.